Skip to content
Tenfell
Awarded contract
Published 25 Nov 2021

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England

NHS England · London

Key facts

Awarded
15 Nov 2021
Contract starts
01 Jan 2022
Contract ends
31 Mar 2024
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 3 suppliers

SupplierValue
Bayer plc—
Bristol Myers Squibb—
Daiichi Sankyo UK Ltd—

Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).

Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.